IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$74.48 USD
+0.12 (0.16%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.42 -0.06 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This reflects a positive earnings surprise of 11.11%. Look out for ITCI's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 32%.
Earnings History
Price & Consensus
Zacks News for ITCI
Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Tops Revenue Estimates
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services